Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant

NCT06725121 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)
Macrovascular Invasion
Liver Transplant Surgery
Downstaging

Interventions

BIOLOGICAL: Atezolizumab & Bevacizumab
DRUG: Yttrium-90 (Y-90)
RADIATION: Stereotactic body radiotherapy (SBRT)

Sponsor

University Health Network, Toronto